Compare Lufax Holding Ltd (LU) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lufax Holding Ltd vs Marsh & McLennan Companies, Inc. — how do they compare? Lufax Holding Ltd trades at $0.98 (market cap $982.89M), while Marsh & McLennan Companies, Inc. trades at $175.76 (market cap $84.31B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 85.8× Lufax Holding Ltd's market cap, and Marsh & McLennan Companies, Inc. pays a 2.24% dividend while Lufax Holding Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lufax Holding Ltd for 13 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.
| LU | MRSH | |
|---|---|---|
Market Cap | $982.89M | $84.31B |
Volume | 3,323,384 | 3,948,947 |
Sector | Financials | Financials |
52-Week High | $3.78 | $207.02 |
52-Week Low | $0.95 | $157.32 |
Typical Hold Time | 13 Days | 109 Days |
Enterprise Value | $58.81B | $104.99B |
Dividend Yield | — | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lufax Holding Ltd (LU) trades at $0.9467, down 3.54% on the day, reflecting persistent bearish technical signals and fundamental challenges. The company reported a net loss of $2.10 billion in 2025 with revenue declining to $21.7 billion in 2026, though it maintains a low P/S of 0.25 and P/B of 0.07. Recent corporate actions include a 10:1 reverse stock split effective October 23, 2026, aimed at compliance, while analyst consensus remains predominantly buy-rated despite earnings misses.
The outlook hinges on Lufax's ability to stabilize revenue and narrow losses amid regulatory pressures in China's consumer lending sector. Deep value arguments based on tangible book value and Ping An backing present a speculative opportunity, but execution risks and sustained negative cash flows pose significant threats to near-term shareholder value.
Marsh (MRSH) trades at $176.67, up 1.73% today, with a bullish technical trend and strong support at $174. The company shows robust fundamentals, with revenue growing to $26.98B in 2025 and a net income margin of 14.24%. Recent acquisition of Accel Holdings (Business Wire, 2026-10-02) may enhance growth. Earnings have consistently beaten estimates in recent quarters, with Q3 2026 results pending.
Outlook is positive with a consensus price target of $202.71 (MarketBeat, 2026-09-30), offering ~15% upside. Risks include competitive pressures and market volatility. Analyst sentiment is mixed, with 32% buy ratings but 65% hold, suggesting cautious optimism amid solid execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
